Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
unknown

Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH

NCT05600959
unknown

DNA Exome Sequencing TCM for Sjögren's Syndrome

NCT03935373
completed

Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion

NCT01256801
completednot_applicable

Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease

NCT00629603

Clinical Trials (4)

Showing 4 of 4 trials
NCT05600959

Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH

Unknown
NCT03935373

DNA Exome Sequencing TCM for Sjögren's Syndrome

Unknown
NCT01256801

Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion

Completed
NCT00629603Not Applicable

Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4